Jasper Therapeutics, Inc.
JSPR$39M
Micro CapNASDAQBiological Products, (No Diagnostic Substances)🇺🇸North AmericaREDWOOD CITY27 employees
Drugs in Pipeline
1
Phase 3 Programs
0
Upcoming Catalysts
3
Next Catalyst
Apr 1, 2026
28dMarket Overview
Stock performance and key metrics
JSPR News
Catalyst Timeline
3 upcoming, 0 past
Drug Pipeline
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
Briquilimab | Phase 2 | Chronic Spontaneous Urticaria | - | - |
Source: CatalystAlert database (ClinicalTrials.gov, SEC EDGAR)
Regulatory Approvals
Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply